Dew, I agree the CC was very encouraging with more irons in the fire than the past. If that was you asking the last question, and I think is was, the Merrimack information is very important and they have always been deliberately vague in the area. My question is that I am unsure as to what biogenerics refers to as well as follow on biologics. Does this mean the agents like Enbrel or Tysabri will lose patent protection and then be made by goats? Thanks, bp